便潜血検査市場レポート：検査タイプ、最終用途、地域別、2025-2033

便潜血検査市場の世界市場規模は、2024年に14億2,690万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに21億4,220万米ドルに達し、2025年から2033年にかけて4.15%の成長率（CAGR）を示すと予測しています。大腸がんの有病率の上昇、非侵襲的検査技術の著しい進歩、認知度の向上とスクリーニングプログラム、がんの早期発見と予防のための政府のイニシアチブの高まり、人口の高齢化などが市場成長を促進する主な要因です。

便潜血検査（FOBT）は、便や便に潜む血液を検出するための非侵襲的な検査法です。カードと流せる試薬パッドまたはティッシュを用いてサンプルを採取することにより実施されます。これらのサンプルは検査のために検査室に送られ、痔、憩室症、潰瘍、大腸炎、良性腫瘍、大腸ポリープやがんなど、消化管内で出血を起こす疾患の診断に使用されます。現在、早期スクリーニングに対する意識の高まりが便潜血検査の採用を促進しています。迅速な医療判断を可能にし、効果的なヘルスケアを提供し、生活の質の向上と死亡率の低下につながるからです。

ポイントオブケア診断（POCD）志向の高まりと相まって、患者の体感と健康アウトカムを改善するための統合医療サービスへの注目が高まっていることは、市場成長を刺激する主要因の1つです。これとは別に、老年人口が増加していることも、加齢に伴って疾病に罹患するリスクが高まるため、市場の成長を加速させています。その結果、さまざまな国の行政機関が高齢者向けのFOBTスクリーニングプログラムを実施しています。さらに、低侵襲（MI）手技の普及が市場の成長に寄与しています。これに加えて、免疫化学的便潜血検査（iFOBTまたはFIT）は使いやすく、がんや進行腺腫に対する臨床的感度が高いため、人気を集めています。FOBT装置はオンライン小売店で簡単に入手できるため、今後数年間は市場の成長にプラスの影響を与えると予想されます。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の便潜血検査市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：検査タイプ別

• グアイアックFOB便検査
  • 市場動向
  • 市場予測
• 免疫FOB凝集試験
  • 市場動向
  • 市場予測
• ラテラルフロー免疫FOB検査
  • 市場動向
  • 市場予測
• 免疫FOB ELISA検査
  • 市場動向
  • 市場予測

第7章 市場内訳：最終用途別

• 病院
  • 市場動向
  • 市場予測
• 臨床診断検査室
  • 市場動向
  • 市場予測
• 医師オフィスラボ
  • 市場動向
  • 市場予測

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第9章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• バイヤー交渉力
• サプライヤーの交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Beckman Coulter Inc.（Danaher Corporation）
  • Biohit Oyj
  • EDP Biotech Corporation
  • Eiken Chemical Co. Ltd.
  • Epigenomics AG
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Randox Laboratories Ltd.

List of Figures

• Figure 1: Global: Fecal Occult Testing Market: Major Drivers and Challenges
• Figure 2: Global: Fecal Occult Testing Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Fecal Occult Testing Market: Breakup by Test Type (in %), 2024
• Figure 5: Global: Fecal Occult Testing Market: Breakup by End User (in %), 2024
• Figure 6: Global: Fecal Occult Testing Market: Breakup by Region (in %), 2024
• Figure 7: Global: Fecal Occult Testing (Guaiac FOB Stool Test) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 8: Global: Fecal Occult Testing (Guaiac FOB Stool Test) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Global: Fecal Occult Testing (Immuno-FOB Agglutination Test) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Fecal Occult Testing (Immuno-FOB Agglutination Test) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Fecal Occult Testing (Lateral Flow Immuno-FOB Test) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Fecal Occult Testing (Lateral Flow Immuno-FOB Test) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Fecal Occult Testing (Immuno-FOB ELISA Test) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Fecal Occult Testing (Immuno-FOB ELISA Test) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Fecal Occult Testing (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Fecal Occult Testing (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Fecal Occult Testing (Clinical Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Fecal Occult Testing (Clinical Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Fecal Occult Testing (Physician Office Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Fecal Occult Testing (Physician Office Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: North America: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: United States: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: United States: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Canada: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Canada: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: North America: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Asia-Pacific: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: China: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: China: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: Japan: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: Japan: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: India: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: India: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: South Korea: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: South Korea: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Australia: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Australia: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: Indonesia: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: Indonesia: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: Others: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: Others: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: Asia-Pacific: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Europe: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Germany: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: Germany: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: France: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: France: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: United Kingdom: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: United Kingdom: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Italy: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Italy: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: Spain: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: Spain: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Russia: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Russia: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: Others: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Others: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: Europe: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Latin America: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Brazil: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Brazil: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Mexico: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Mexico: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Others: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Others: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Latin America: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Middle East and Africa: Fecal Occult Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Middle East and Africa: Fecal Occult Testing Market: Breakup by Country (in %), 2024
• Figure 69: Middle East and Africa: Fecal Occult Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Global: Fecal Occult Testing Industry: SWOT Analysis
• Figure 71: Global: Fecal Occult Testing Industry: Value Chain Analysis
• Figure 72: Global: Fecal Occult Testing Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Fecal Occult Testing Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Fecal Occult Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
• Table 3: Global: Fecal Occult Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 4: Global: Fecal Occult Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 5: Global: Fecal Occult Testing Market: Competitive Structure
• Table 6: Global: Fecal Occult Testing Market: Key Players

The global fecal occult testing market size reached USD 1,426.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,142.2 Million by 2033, exhibiting a growth rate (CAGR) of 4.15% during 2025-2033. The rising prevalence of colorectal cancer, significant advancements in non-invasive testing technologies, increasing awareness and screening programs, growing government initiatives for early cancer detection and prevention, and rising aging populations are some of the major factors propelling the market growth.

A fecal occult blood test (FOBT) is a noninvasive procedure used to detect hidden blood in the feces or stool. It is performed by collecting samples using cards and flushable reagent pads or tissues. These samples are sent to the laboratory for testing and are used to diagnose conditions such as hemorrhoids, diverticulosis, ulcers, colitis, benign tumors and colon polyps or cancer, which cause bleeding in the digestive tract. At present, the growing awareness about early screening is promoting the adoption of fecal occult testing, as it enables quick medical decisions, provides effective healthcare, and leads to improved quality of life and the reduced mortality rate.

The rising focus on integrated health services for improved patient experience and health outcomes, in confluence with the increasing inclination towards point-of-care diagnostics (POCD), represents one of the key factors stimulating the market growth. Apart from this, the rising geriatric population is accelerating the growth of the market as the risk of contracting diseases increases with age. As a result, governing agencies of various countries are implementing several FOBT screening programs for older adults. Furthermore, the widespread adoption of minimally invasive (MI) procedures is contributing to the growth of the market. Besides this, immunochemical fecal occult blood tests (iFOBTs or FITs) are gaining traction as they are easy to use and clinically more sensitive to cancers and advanced adenomas. The easy availability of FOBT devices at online retail stores is anticipated to create a positive impact on the market growth in the upcoming years.

Fecal Occult Testing Market Segmentation:

Breakup by Test Type:

Guaiac FOB Stool Test

Immuno-FOB Agglutination Test

Lateral Flow Immuno-FOB Test

Immuno-FOB ELISA Test

Breakup by End User:

Hospitals

Clinical Diagnostic Laboratories

Physician Office Laboratories

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Biohit Oyj, EDP Biotech Corporation, Eiken Chemical Co. Ltd., Epigenomics AG, Quest Diagnostics Incorporated, Quidel Corporation and Randox Laboratories Ltd.

Key Questions Answered in This Report:

• How has the global fecal occult testing market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global fecal occult testing market?
• What is the impact of each driver, restraint, and opportunity on the global fecal occult testing market?
• What are the key regional markets?
• Which countries represent the most attractive fecal occult testing market?
• What is the breakup of the market based on the test type?
• Which is the most attractive test type in the fecal occult testing market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the fecal occult testing market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global fecal occult testing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Fecal Occult Testing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Test Type

• 6.1 Guaiac FOB Stool Test
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Immuno-FOB Agglutination Test
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Lateral Flow Immuno-FOB Test
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Immuno-FOB ELISA Test
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Clinical Diagnostic Laboratories
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Physician Office Laboratories
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Abbott Laboratories
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Beckman Coulter Inc. (Danaher Corporation)
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 Biohit Oyj
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
  • 13.3.4 EDP Biotech Corporation
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 Eiken Chemical Co. Ltd.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 Epigenomics AG
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Quest Diagnostics Incorporated
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Quidel Corporation
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Randox Laboratories Ltd.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio